Patent Assignment
Reel/Frame 067203/0398
Assignment of Assignor's Interest
Recorded: 2024-04-23
Pages: 61
Assignor
ENDO PHARMACEUTICALS INC.
Executed: 2024-04-23
Assignee
ENDO USA, INC.
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
Covered Properties
(30)
Sustained Release Formulations of Oxymorphone
Oxymorphone controlled release formulations
Sustained Release Formulations of Metformin
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,229,636 →
Application:
10/787,385 →
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,404,489 →
Application:
10/814,399 →
Delayed Release Dosage Forms
Oxymorphone Controlled Release Formulations
Sustained release formulations of nalbuphine
Oxymorphone Controlled Release Formulations
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Sustained Release Formulations of Nalbuphine
Vitamin B12 Nasal Spray and Method of Use
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Sustained Release Formulation of Nalbuphine
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Sustained Release Formulation of Nalbuphine
Sustained Release Formulation of Nalbuphine
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Vitamin B12 Nasal Spray and Method of Use
Vitamin B12 Nasal Spray and Method of Use
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Sustained Release Formulation of Nalbuphine
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Sustained Release Formulations of Nalbuphine
Oxymorphone Controlled Release Compositions
Application:
17/035,453 →
Publication:
US 2021/0008063
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Application:
17/838,636 →
Publication:
US 2022/0313688
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Grant of Security Interest in Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Assignment of Assignor's Interest
Mar 17, 2015
From: GRÜNENTHAL GMBH
To: ENDO PHARMACEUTICALS, INC.
Reel/Frame 035184/0493 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: PAR PHARMACEUTICAL, INC.; ENDO GENERICS HOLDINGS, INC.; INNOTEQ, INC.
Reel/Frame 042171/0036 →
Security Interest
Jun 8, 2017
From: PAR PHARMACEUTICAL, INC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0216 →
Security Interest
Jun 8, 2017
From: ENDO PHARMACEUTICALS INC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042742/0922 →
Assignment of Assignor's Interest
Jul 27, 2017
From: PAR PHARMACEUTICAL, INC.; ENDO PAR INNOVATION COMPANY, LLC
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 043118/0747 →
Confirmatory Grant of Security Interest in United States Patents
Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0618 →
Confirmatory Grant of Security Interest in United States Patents
Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
Merger and Change of Name
May 6, 2021
From: PENWEST PHARMACEUTICALS CO.; ENDO PHARMACEUTICALS INC.
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 056159/0769 →
Confirmatory Grant of Security Interest in United States Patents
Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0491 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0542 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
Assignment of Assignor's Interest
Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
Security Interest
Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest
Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →